SCHEMBL16608697

SCHEMBL16608697

CCS(=O)(=O)c1ccnc(S(=O)(=O)CC)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.35
TP53 P04637 4/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
THRB P10828 1/20 0.35
MEN1 O00255 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
KMT2A Q03164 2/20 0.35
PAX8 Q06710 1/20 0.35
TLR9 Q9NR96 1/20 0.35
PSIP1 O75475 2/20 0.34
COMT P21964 1/20 0.33
LMNA P02545 1/20 0.32
GAA P10253 2/20 0.31
RIPK1 Q13546 2/20 0.31
SDHB P21912 1/20 0.31
NPSR1 Q6W5P4 2/20 0.30
KDM4E B2RXH2 1/20 0.30
APOBEC3G Q9HC16 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10872794 0.80 NPSR1 (0.44) MAPTTP53SMN1; SMN2THRBMEN1
SCHEMBL27733018 0.80 PSIP1 (0.34) MAPTPSIP1COMTLMNAGAA
SCHEMBL30744221 0.78 TSHR (0.34) MAPTTP53SMN1; SMN2THRBMEN1
SCHEMBL16232098 0.76 SDHB (0.37) MAPTTP53SMN1; SMN2THRBMEN1
SCHEMBL10727966 0.73 COMT (0.43) MAPTTP53SMN1; SMN2THRBKMT2A
SCHEMBL1750195 0.71 PARP1 (0.38) MAPTTP53SMN1; SMN2MEN1NPC1
SCHEMBL27868514 0.70 HSP90AA1 (0.54) NPC1RAB9ALMNAKDM4E
SCHEMBL19422050 0.69 HSP90AA1 (0.37) MAPTNPC1KMT2APSIP1COMT
SCHEMBL16608855 0.68 LMNA (0.37) SMN1; SMN2THRBPSIP1LMNAGAA
SCHEMBL2643226 0.68 PSIP1 (0.34) PSIP1COMTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015048246-A1 TETRA-ARYL CYCLOBUTANE INHIBITORS OF ANDROGEN RECEPTOR ACTION FOR THE TREATMENT OF HORMONE REFRACTORY CANCER THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2015-04-02 WO disclosed